Moderna
MRNA
#1082
Rank
HK$140.10 B
Marketcap
HK$364.08
Share price
-6.86%
Change (1 day)
-32.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -HK$33.68 Billion

According to Moderna 's latest financial reports the company's current earnings are HK$4.98 Billion. In 2023 the company made an earning of -HK$30.36 Billion a decrease over its 2022 earnings that were of HK$74.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$33.68 Billion10.95%
2023 -HK$30.36 Billion-140.65%
2022 HK$74.66 B-27.81%
2021 HK$103.42 B-1911.15%
2020 -HK$5.72 Billion44.7%
2019 -HK$3.95 Billion28.63%
2018 -HK$3.07 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.28 Billion-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$128.20 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.33 Billion-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.46 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$98.98 B-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$4.09 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.01 B-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.92 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA